Abstract

ARRUNATEGUI, Ana María et al. Technical and clinical aspects of the histocompatibility crossmatch assay in solid organ transplantation. Biomed. [online]. 2022, vol.42, n.2, pp.391-413.  Epub June 01, 2022. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.6255.

The presence of antibodies directed against human leukocyte antigens (HLA) expressed on donor cells is a significant risk factor for serious clinical complications after transplantation. The crossmatch assay is one of the most important tests available for the detection of donor-specific antibodies in potential allograft recipients. Early crossmatch methods utilized complement-dependent cytotoxicity, which is useful for detecting the donor-specific anti- HLA antibodies responsible for hyperacute allograft rejection but lacks adequate sensitivity. Consequently, more sensitive crossmatch methods have been developed, ultimately leading to the flow cytometry crossmatch as the currently preferred methodology.

Herein, we review the evolution of the crossmatch assay and the most important factors to consider when performing and interpreting the results of this fundamental assay for ensuring the long-term survival of the transplanted organ.

Keywords : Organ transplantation; HLA antigens; histocompatibility; cytotoxicity tests, immunologic; flow cytometry.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )